What is AbCellera Biologics Inc.'s other current assets?

AbCellera Biologics Inc. (ABCL) reported other current assets of $98.1M in Q1 2026.

How has AbCellera Biologics Inc.'s other current assets changed year-over-year?

AbCellera Biologics Inc.'s other current assets increased by 3.6% year-over-year, from $94.71M to $98.1M.

What is the long-term trend for AbCellera Biologics Inc.'s other current assets?

Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s other current assets has grown at a 79.5% compound annual growth rate (CAGR), from $5.97M to $111.11M.

AbCellera Biologics Inc. ABCL Other current assets

Other current assets at other companies

Bristol-Myers SquibbBMY

$4.6B-16.9%

Twist Bioscience CorporationTWST

——

Recursion Pharmaceuticals, Inc.RXRX

——

Roivant SciencesROIV

——

Arrowhead ResearchARWR

——

RevvityRVTY

——

Other financials

Income statement

See full

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

See full

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

See full

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

See full

Market cap$1.84B+59.2%

Enterprise value$1.88B+100.0%

P/S23.3×-26.8×

Profitability

See full

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

See full

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbCellera Biologics Inc.'s other current assets?: AbCellera Biologics Inc. (ABCL) reported other current assets of $98.1M in Q1 2026.
How has AbCellera Biologics Inc.'s other current assets changed year-over-year?: AbCellera Biologics Inc.'s other current assets increased by 3.6% year-over-year, from $94.71M to $98.1M.
What is the long-term trend for AbCellera Biologics Inc.'s other current assets?: Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s other current assets has grown at a 79.5% compound annual growth rate (CAGR), from $5.97M to $111.11M.